Olgu Sunumu
BibTex RIS Kaynak Göster

İntraoperatif kardiyomyopati gelişen plasenta perkreata olgusunda perioperatif anemi yönetimi

Yıl 2020, Cilt: 11 Sayı: 4, 334 - 337, 30.09.2020
https://doi.org/10.18663/tjcl.753969

Öz

Elektif cerrrahi planmalasında hastada bulunan demir eksikliği anemisinin preoperatif tedavi edilmesi morbidite ve mortalitede azalma ile ilişkili bulunmuştur. Oral demir tedavisinin yetersiz kaldığı ya da operasyon öncesi sürenin kısıtlı olduğu durumlarda İV demir tedavisi uygulanmalıdır. Gebelerde preoperatif dönemde klinik semptomu olmasa bile intraoperatif ya da postoperatif dönemde peripartum kardiyomyopati (PPKMP) gelişebileceği her zaman akılda bulundurulmalıdır.Bu olgu sunumuyla plasental invazyon anomalisi bulunan, sezaryen operasyonu sırasında ani KMP gelişen, peroperatif anemi tedavisi için intravenöz demir tedavisi uyguladığımız gebe hastayı güncel literatür ışığında tartışmayı amaçladık.

Destekleyen Kurum

Destekleyen kurum bulunmamaktadır

Proje Numarası

yok

Kaynakça

  • 1. WHO. Iron deficiency anaemia : assessment, prevention and control : a guide for programme managers. In: Development NfHa ed. Geneva: World Health Organization; 2001
  • 2. Reveiz L, Gyte GM, Cuervo LG, Casasbuenas A. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev 2011(10):CD003094.
  • 3. Muñoz M, Acheson AG, Auerbach M et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia 2017; 72: 233-47.
  • 4. Jose A, Mahey R, Sharma JB et al. Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial. BMC Pregnancy Childbirth 2019; 19: 54.
  • 5. Özterlemez NT, Işık G, İnan G, Günaydın B. Aritmi ablasyon öyküsü olan gebenin spinal anestezi eşliğinde sezaryenle doğumunda anemi yönetimi. Turk J Clin Lab 2020; 2: 85-88.
  • 6. Marsoosi V, Ghotbizadeh F, Hashemi N, Molaei B. Development of a scoring system for prediction of placenta accreta and determine the accuracy of its results. J Matern Fetal Neonatal Med 2020; 33: 1824-30.
  • 7. Hibbard JU, Lindheimer M, Lang RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol 1999; 94: 311-6
  • 8. Zagelbaum NK, Bhinder J, Gupta CA, Frishman WH, Aronow WS. Peripartum Cardiomyopathy Incidence, Risk Factors, Diagnostic Criteria, Pathophysiology, and Treatment Options. Cardiol Rev 2020; 28: 148-55.
  • 9. Unyime S Ituk 1, Ashraf S Habib, Carrie M Polin, Terrence K Allen. Anesthetic Management and Outcomes of Parturients With Dilated Cardiomyopathy in an Academic Centre. Can J Anaesth 2015; 62: 278-88.
  • 10. Shannon-Cain J, Hunt E, Cain BS. Multidisciplinary management of peripartum cardiomyopathy during repeat caesarean delivery: A case report. AANA J 2008; 76: 443-7.

Management of perioperative anemia in a case of placenta percreata who had intraoperative cardiomyopathy

Yıl 2020, Cilt: 11 Sayı: 4, 334 - 337, 30.09.2020
https://doi.org/10.18663/tjcl.753969

Öz

Preoperative treatment of iron deficiency anemia was associated with a decrease in morbidity and mortality. IV iron therapy should be used in cases where oral iron therapy is insufficient or the time before operation is limited. It should always be kept in mind that pregnant women can develop peripartum cardiomyopathy (PPCMP) in the intraoperative or postoperative period, even if they do not have clinical symptoms in the preoperative period. With this case report, we aimed to discuss the pregnant patient who has placental invasion anomaly, who developed sudden CMP during cesarean operation, and we applied intravenous iron therapy for the treatment of peroperative anemia in the light of current literature.

Proje Numarası

yok

Kaynakça

  • 1. WHO. Iron deficiency anaemia : assessment, prevention and control : a guide for programme managers. In: Development NfHa ed. Geneva: World Health Organization; 2001
  • 2. Reveiz L, Gyte GM, Cuervo LG, Casasbuenas A. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev 2011(10):CD003094.
  • 3. Muñoz M, Acheson AG, Auerbach M et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia 2017; 72: 233-47.
  • 4. Jose A, Mahey R, Sharma JB et al. Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial. BMC Pregnancy Childbirth 2019; 19: 54.
  • 5. Özterlemez NT, Işık G, İnan G, Günaydın B. Aritmi ablasyon öyküsü olan gebenin spinal anestezi eşliğinde sezaryenle doğumunda anemi yönetimi. Turk J Clin Lab 2020; 2: 85-88.
  • 6. Marsoosi V, Ghotbizadeh F, Hashemi N, Molaei B. Development of a scoring system for prediction of placenta accreta and determine the accuracy of its results. J Matern Fetal Neonatal Med 2020; 33: 1824-30.
  • 7. Hibbard JU, Lindheimer M, Lang RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol 1999; 94: 311-6
  • 8. Zagelbaum NK, Bhinder J, Gupta CA, Frishman WH, Aronow WS. Peripartum Cardiomyopathy Incidence, Risk Factors, Diagnostic Criteria, Pathophysiology, and Treatment Options. Cardiol Rev 2020; 28: 148-55.
  • 9. Unyime S Ituk 1, Ashraf S Habib, Carrie M Polin, Terrence K Allen. Anesthetic Management and Outcomes of Parturients With Dilated Cardiomyopathy in an Academic Centre. Can J Anaesth 2015; 62: 278-88.
  • 10. Shannon-Cain J, Hunt E, Cain BS. Multidisciplinary management of peripartum cardiomyopathy during repeat caesarean delivery: A case report. AANA J 2008; 76: 443-7.
Toplam 10 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular Sağlık Kurumları Yönetimi
Bölüm Olgu Sunumu
Yazarlar

Ayça Taş Tuna

Havva Kocayigit

Fatih Şahin

Koray Gök

Proje Numarası yok
Yayımlanma Tarihi 30 Eylül 2020
Yayımlandığı Sayı Yıl 2020 Cilt: 11 Sayı: 4

Kaynak Göster

APA Taş Tuna, A., Kocayigit, H., Şahin, F., Gök, K. (2020). İntraoperatif kardiyomyopati gelişen plasenta perkreata olgusunda perioperatif anemi yönetimi. Turkish Journal of Clinics and Laboratory, 11(4), 334-337. https://doi.org/10.18663/tjcl.753969
AMA Taş Tuna A, Kocayigit H, Şahin F, Gök K. İntraoperatif kardiyomyopati gelişen plasenta perkreata olgusunda perioperatif anemi yönetimi. TJCL. Eylül 2020;11(4):334-337. doi:10.18663/tjcl.753969
Chicago Taş Tuna, Ayça, Havva Kocayigit, Fatih Şahin, ve Koray Gök. “İntraoperatif Kardiyomyopati gelişen Plasenta Perkreata Olgusunda Perioperatif Anemi yönetimi”. Turkish Journal of Clinics and Laboratory 11, sy. 4 (Eylül 2020): 334-37. https://doi.org/10.18663/tjcl.753969.
EndNote Taş Tuna A, Kocayigit H, Şahin F, Gök K (01 Eylül 2020) İntraoperatif kardiyomyopati gelişen plasenta perkreata olgusunda perioperatif anemi yönetimi. Turkish Journal of Clinics and Laboratory 11 4 334–337.
IEEE A. Taş Tuna, H. Kocayigit, F. Şahin, ve K. Gök, “İntraoperatif kardiyomyopati gelişen plasenta perkreata olgusunda perioperatif anemi yönetimi”, TJCL, c. 11, sy. 4, ss. 334–337, 2020, doi: 10.18663/tjcl.753969.
ISNAD Taş Tuna, Ayça vd. “İntraoperatif Kardiyomyopati gelişen Plasenta Perkreata Olgusunda Perioperatif Anemi yönetimi”. Turkish Journal of Clinics and Laboratory 11/4 (Eylül 2020), 334-337. https://doi.org/10.18663/tjcl.753969.
JAMA Taş Tuna A, Kocayigit H, Şahin F, Gök K. İntraoperatif kardiyomyopati gelişen plasenta perkreata olgusunda perioperatif anemi yönetimi. TJCL. 2020;11:334–337.
MLA Taş Tuna, Ayça vd. “İntraoperatif Kardiyomyopati gelişen Plasenta Perkreata Olgusunda Perioperatif Anemi yönetimi”. Turkish Journal of Clinics and Laboratory, c. 11, sy. 4, 2020, ss. 334-7, doi:10.18663/tjcl.753969.
Vancouver Taş Tuna A, Kocayigit H, Şahin F, Gök K. İntraoperatif kardiyomyopati gelişen plasenta perkreata olgusunda perioperatif anemi yönetimi. TJCL. 2020;11(4):334-7.


e-ISSN: 2149-8296

The content of this site is intended for health care professionals. All the published articles are distributed under the terms of

Creative Commons Attribution Licence,

which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.